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Abstract
Background: The loop-mediated isothermal amplification (LAMP) assay, with its advantages of simplicity, rapidity and cost
effectiveness, has evolved as one of the most sensitive and specific methods for the detection of a broad range of
pathogenic microorganisms including African trypanosomes. While many LAMP-based assays are sufficiently sensitive to
detect DNA well below the amount present in a single parasite, the detection limit of the assay is restricted by the number
of parasites present in the volume of sample assayed; i.e. 1 per mL or 103 per mL. We hypothesized that clinical sensitivities
that mimic analytical limits based on parasite DNA could be approached or even obtained by simply adding detergent to
the samples prior to LAMP assay.
Methodology/Principal Findings: For proof of principle we used two different LAMP assays capable of detecting 0.1 fg
genomic DNA (0.001 parasite). The assay was tested on dilution series of intact bloodstream form Trypanosoma brucei
rhodesiense in human cerebrospinal fluid (CSF) or blood with or without the addition of the detergent Triton X-100 and
60 min incubation at ambient temperature. With human CSF and in the absence of detergent, the LAMP detection limit for
live intact parasites using 1 mL of CSF as the source of template was at best 103 parasites/mL. Remarkably, detergent
enhanced LAMP assay reaches sensitivity about 100 to 1000-fold lower; i.e. 10 to 1 parasite/mL. Similar detergent-mediated
increases in LAMP assay analytical sensitivity were also found using DNA extracted from filter paper cards containing blood
pretreated with detergent before card spotting or blood samples spotted on detergent pretreated cards.
Conclusions/Significance: This simple procedure for the enhanced detection of live African trypanosomes in biological
fluids by LAMP paves the way for the adaptation of LAMP for the economical and sensitive diagnosis of other protozoan
parasites and microorganisms that cause diseases that plague the developing world.
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Introduction
Tsetse fly-transmitted African trypanosomes are major pathogens
of humans and livestock. Two subspecies of Trypanosoma brucei (T. b.
rhodesiense and T. b. gambiense) cause human African trypanosomiasis
(HAT, commonly called sleeping sickness). After replicating at the
tsetse fly bite site, trypanosomes enter the hemolymphatic system
(early stage or stage 1) (5, 9). Without treatment, the parasites go on
to invade the central nervous system (CNS; late stage or stage 2), a
process that takes months to years with T. b. gambiense (West and
Central African HAT) or weeks to months with T. b. rhodesiense (East
African HAT). The parasites cause a meningoencephalitis leading
to progressive neurologic involvement with concomitant psychiatric
disorders, fragmentation of the circadian sleep-wake cycle and
ultimately to death if untreated (4, 5, 9).
A key issue in the treatment of HAT is to distinguish stage 1
from stage 2 disease, as the drugs used for the treatment of stage 2
need to cross the blood-brain barrier [1,2]. The most widely used
drug is melarsoprol (developed in 1949), which is effective for T. b.
gambiense and T. b. rhodesiense HAT, but unfortunately, melarsoprol
leads to severe and fatal encephalitis in about 5–10% of recipients
despite treatment for this condition [3,4,5]. Therefore, where
HAT is endemic, accurate staging is critical, because failure to
treat CNS involvement leads to death, yet inappropriate CNS
treatment exposes an early-stage patient unnecessarily to highly
toxic and life-threatening drugs.
The diagnosis of HAT in the rural clinical setting, where most
patients are found, still relies largely on the detection of
parasitemia by blood smear and/or CSF microscopy [6,7]. While
T. b. rhodesiense detection in blood is frequently successful, T. b.
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gambiense infections, which constitute over 90% of all HAT cases,
typically show very low parasitemias, and concentration tech-
niques such as centrifugation or mini-anion exchange columns are
usually necessary [6,7,8]. Stage determination still relies on lumbar
puncture to examine CSF for trypanosomes or white cell count/
protein concentration suggestive of chronic meningoencephalitis.
Threshold values for these parameters are controversial, with the
conventional value for stage 2 (.5 cells/mL) now increased to .10
or even 20 cells/mL [9]. In summary, diagnosis and staging of
HAT is currently time consuming, intensive and difficult.
DNA-based diagnostic methods such as PCR and LAMP now
offer greater sensitivity than existing diagnostic methods, detecting
DNA from the equivalent of 0.01 parasites or less. Based on PCR
protocols for HAT [10], we described LAMP targeting the
conserved paraflagellar rod A (PRFA) gene in all T. brucei
subspecies and T. evansi [11]. LAMP is an isothermal DNA
amplification method with excellent analytical sensitivity and
specificity when employed for the detection of a variety of
microorganisms (reviewed in [12]), including human and animal
infective African trypanosomes [11,13,14,15,16,17,18,19,20,21].
LAMP relies on autocycling strand displacement coupled to DNA
synthesis by Bst DNA polymerase, a reaction similar to rolling-
circle amplification [22] but with the added advantage that a heat-
denaturing step is not necessary to initiate rounds of amplification.
Specificity is dictated by four primers (F3, B3, FIP and BIP), and
the addition of two loop primers (LoopF and LoopB) significantly
reduces the reaction time [23].
LAMP is cost-effective (,1 US dollar/test), simple (the
isothermal reaction requires a simple heating device), and rapid
(within 60 minutes) [12,24]. Furthermore, Bst DNA polymerase
can be stored for weeks at ambient temperatures, a critical
property where maintaining a cold chain is difficult [13]. Positive
reactions are indicated by turbidity [25], color changes after
addition of hydroxynaphthol blue (HNB) [26], or changes in
fluorescence using indicator dyes [26,27,28].
Despite its advantages, the usefulness of LAMP for HAT
diagnosis is handicapped in the clinical setting by its inability to
directly detect live trypanosomes in blood or CSF below 1
parasite/mL (103 parasites/mL), the practical detection limit based
on a 1 mL sample volume often used in LAMP or PCR assays.
While sensitivity can be increased 5–10 fold by adding more
sample volume, significant improvement in the assay system for
the detection of live parasites in biologically relevant samples
would clearly be of benefit for diagnosis. Here, we introduce a very
simple modification to the LAMP assay recognizing multi-copy
gene targets that can increase the analytical sensitivity for the
detection of live parasites 100-fold or more.
Materials and Methods
LAMP
Two LAMP primer sets were tested. Data on analytical sensitivity
and specificity of a LAMP primer set for trypanosome DNA based
on the multicopy (approximately 500 copies) repetitive insertion
mobile element (RIME) of subgenus Trypanozoon (GenBank
Accession No. K01801) is well-documented [16,26,29]. Using
between 2–4 mL sample, this pan-T. brucei assay is reported to detect
DNA from,0.001 trypanosome [16]. LAMP primers based on the
serum resistance associated (SRA) gene (GenBank AJ560644) (see
Table S1 for gene sequence) were designed using PrimerExplorer
version 4 software (http://primerexplorer.jp/e/) to create the basic
F3, B3, FIP, BIP [30] and loop LF, LB [23] primers (Fig. 1A). As this
assay recognized more than the SRA gene, this primer set is
designated PSEUDO-SRA. All RIME and PSEUDO-SRA LAMP
primers were synthesized and HPLC purified. For comparison, we
also used the SRA gene (GenBank accession number Z37159)-
specific LAMP assay [17]. Genomic DNA was prepared by using
Qiagen DNeasy Blood & Tissue Kits.
The LAMP reaction was performed as previously described
[11,14,15]. Briefly, the reaction contained 12.5 mL of 2x LAMP
buffer (40 mM Tris-HCl [pH 8.8], 20 mM KCl, 16 mM MgSO4,
20 mM [NH4]2SO4, 0.2% Tween 20, 1.6 M Betaine, 2.8 mM of
each deoxyribonucleotide triphosphate), 1.0 mL primer mix
(5 pmol each of F3 and B3, 40 pmol each of FIP and BIP) or
1.3 mL when LF and LB (20 pmol each) were included, 1 mL (8
units) Bst DNA polymerase (New England Biolabs, Tokyo, Japan),
1 mL of template DNA. Final volumes were adjusted to 25 mL with
distilled water. All reactions were conducted in 2 to 4 replicates
and were monitored in real-time in a LoopampH real-time
turbidimeter LA320C (Teramecs, Tokyo, Japan). The optimal
reaction temperatures were 62uC (RIME LAMP) and 63uC
(PSEUDO-SRA LAMP). The reaction was terminated by
increasing the temperature to 80uC for 5 min. In addition to
turbidity, the amplified products were analyzed on 2% agarose
gels using the E-Gel EX system with ethidium bromide or SYBR
green incorporated into the gels (Invitrogen), and/or after addition
of hydroxynaphthol blue (HNB) [26] to enable visual detection.
The HNB color change from violet to sky blue has been
consistently interpreted by independent observers as the easiest
to see [26].
Analytical sensitivity using human CSF spiked with
trypanosomes
Human CSF was obtained as discarded samples from The Johns
Hopkins Hospital Microbiology laboratory with approval of the
Johns Hopkins Medicine IRB. CSF were adjusted to contain either
1/20 volume deionized water (untreated CSF) or 1/20 volume 10%
(w/v) Triton X-100 (final concentration 0.5% Triton). A 10% (w/v)
Triton X-100 stock solution was made by adding 1 g Triton X-100
to a final volume of 10 mL DNase/RNase free water (Qiagen). We
used bloodstream form T. b. rhodesiense IL1852, a CSF isolate from a
patient in Kenya [31,32]. Originally thought to be T. b. gambiense it
Author Summary
Human African trypanosomiasis or sleeping sickness is a
fatal disease (if untreated) spread by bloodsucking tsetse
flies. Trypanosome parasites first enter the blood and
lymph and eventually invade the brain. In rural clinical
settings, diagnosis still relies on the detection of these
microbes in blood and cerebrospinal fluid (CSF) by
microscopy. LAMP, or loop-mediated isothermal amplifi-
cation of DNA, is a technique that can specifically detect
very small amounts of DNA from an organism. It is similar
to PCR, the polymerase chain reaction, another DNA
amplification technique widely used for diagnosis of
infectious diseases. LAMP’s advantages are that the
reaction works at one temperature, whereas PCR needs a
thermocycler, and LAMP is not affected by blood
components that inhibit PCR. We show that by simply
adding detergent during sample preparation, the an-
alytical sensitivity of LAMP targeting many gene copies is
greatly improved, presumably because DNA is released
from the pathogen cells and dispersed through the
sample. To demonstrate proof of principle, we used
pathogenic trypanosomes in different human body fluids
(CSF or blood), but this simple modification should be
applicable for diagnosis of other microbial infections
where cells are sensitive to detergent lysis.
LAMP for Detection of Live African Trypanosomes
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Figure 1. PSEUDO-SRA LAMP for the detection of T. b. rhodesiense genomic DNA. The PSEUDO-SRA LAMP primer set (Panel A) was tested
with 1:10 serially diluted T. b. rhodesiense IL1852 DNA (1700 fg to 0.017 fg) (Panel B). Replicates: Samples with DNA, n= 2; without DNA, n= 4. The data
for each individual sample is presented as real-time turbidity values versus LAMP reaction time. As shown in Panel C, 5 mL reaction product after
PSEUDO-SRA LAMP or SRA LAMP amplification of differing concentrations of T. b. rhodesiense IL1852 template were electrophoresed through 2%
agarose gel containing ethidium bromide. From left to right: Lane 1, 1 kb DNA ladder (Fermentas); Lane 2, 17 pg IL 1852 DNA after SRA LAMP (Njiru
[18]). Lane 3, 17 pg IL 1852 DNA after PSEUDO-SRA LAMP. Lanes 4–10, show a dilution series of template IL1852 DNA as follows: Lane 4, 1700 fg;
Lane 5, 170 fg; Lane 6,17 fg; Lane 7, 1.7 fg; Lane 8, 0.17 fg; Lane 9, 0.017 fg; Lane 10, no DNA template.
doi:10.1371/journal.pntd.0001249.g001
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has been reclassified as T. b. rhodesiense [33] based on the presence of
the SRA gene [34] and the absence of the TgsGP gene [35,36] (Fig.
S1). Human CSF was spiked with bloodstream form T. b. rhodesiense
IL1852 and the samples serially diluted 1:10 in CSF with or without
0.5% detergent to cover a range of parasite concentrations from 104
to 1021 parasites/mL. After 60 min incubation at ambient
temperature to allow for lysis, the LAMP assays were done using
1 mL CSF.
Analytical sensitivity using human blood spiked with
trypanosomes
In the field, biological samples are often shipped to another
geographical site for later analyses. They are often preserved by
spotting on paper cards designed for short-term protein, RNA and
DNA storage (2 weeks at ambient temperature) such as Whatman
Protein Saver 903, or long-term (years) DNA storage/archiving on
Whatman FTA cards. To simulate these conditions, human blood
obtained as discarded samples from The Johns Hopkins Hospital
Microbiology laboratory with approval of the Johns Hopkins
Medicine IRB was spiked with T. b. rhodesiense (104 to 1022
parasites/mL). Protein Saver 903 cards were pretreated with
50 mL 0.5% Triton X-100, which was sufficient to fill the
designated circle on the cards, and dried overnight prior to whole
blood spotting. For assay standardization, three 2 mm punches
made from the 1 cm2 dried blood spots (DBS) and DNA was
extracted using standard methods [37]. The LAMP assays were
done using 1 mL DBS DNA template. Alternatively, untreated and
0.5% Triton X-100 treated trypanosome-spiked blood were
spotted on untreated Protein Saver 903 cards and dried overnight
with subsequent DBS DNA extraction as above.
Results and Discussion
LAMP with genomic parasite DNA
Based on experiments repeated at least 3 times, LAMP assays
successfully amplified T. b. rhodesiense DNA within 55–60 min at
62uC (RIME LAMP) or 63uC (PSEUDO-SRA LAMP). As
Figure 2. Detergent increases analytical sensitivity of RIME LAMP for the direct detection of T. b. rhodesiense in human CSF. Fifty mL
water (DNAse/RNAse free) or 10% Triton X-100 was added to human CSF. T. b. rhodesiense IL1852 was spiked into 950 mL human CSF without and
with 0.5% Triton X-100. The samples were serially diluted in duplicate in normal or detergent treated CSF and incubated at ambient temperature for
60 min. One mL aliquots were assayed for 1 hr at 62uC using RIME LAMP primers. Normal CSF (1 mL) with or without Triton X-100 was used as a
control. Each panel shows hydroxynaphthol blue reaction tubes (top), agarose gel (center) and real-time turbidity data (bottom) from the same
samples.
doi:10.1371/journal.pntd.0001249.g002
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reported previously [16], we found that RIME LAMP detected 0.1
fg genomic DNA (0.001 parasite) from T. b. rhodesiense IL1852 (not
shown). PSEUDO-SRA LAMP was as sensitive and reliably
detected 0.1 fg (0.001 parasite) or less T. b. rhodesiense IL1852
genomic DNA (Fig. 1B and 1C). Nonetheless, when using the SRA
gene specific LAMP assay [17] the detection limit for T. b.
rhodesiense IL1852 genomic DNA was 0.1–1.0 pg (1–10 parasites),
comparing favorably to reported values [17].
The standard curves with PSEUDO-SRA LAMP seem to
display biphasic kinetics with an early initial phase (15–20 min)
followed by a late second phase (35 and 55 min) with a break point
around 1.7 fg DNA (Fig. 1B) suggesting that it targets other
genomic components besides the SRA gene. As SRA is a truncated
VSG, it is likely that the PSEUDO-SRA LAMP is amplifying other
VSG sequences, albeit not efficiently (see below). Although the
PSEUDO-SRA LAMP primer sequences were verified as being
unique by BLAST analysis of the T. b. brucei TREU 927 genome
sequence and the VSG database (TriTrypDB: http://tritrypdb.
org/tritrypdb/), VSG repertoires are diverse between strains, and
we were unable to assess the primers against sequences of the full
IL1852 VSG repertoire as its genome has not been sequenced.
The PSEUDO-SRA LAMP was specific and recognized DNA
equally well from other T. b. rhodesiense strains (LouTat 1A, GYBO,
IL1501), but did not recognize DNA from T. b. gambiense isolates
Figure 3. Analytical sensitivity of real-time PSEUDO-SRA LAMP for the direct detection of T. b. rhodesiense in human CSF. T. b.
rhodesiense IL1852 was spiked into human CSF without and with 0.5% Triton X-100 (+Tx). The samples were serially diluted in normal or detergent
treated CSF. After 60 min incubation at ambient temperature, 1 mL aliquots were assayed using the PSEUDO-SRA LAMP primers. Normal CSF with or
without Triton X-100 was used as a control. The data for each individual sample is presented as real-time turbidity values versus LAMP reaction time.
The number of parasites/mL CSF originally present in the sample used for the assays in the panels shown are: [A], 104/mL; [B], 103/mL; [C], 102/mL;
[D], 101/mL; [E], 100/mL; [F], CSF alone.
doi:10.1371/journal.pntd.0001249.g003
LAMP for Detection of Live African Trypanosomes
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(IL 3258, DAL 972, DAL 072, DAL 069, IPR SG-1020, FONT
l993, JUA, MOS, MA 002) (not shown). It also recognized T. b.
brucei strain 927 genomic DNA at very high concentrations (i.e.
.1 ng DNA/mL equivalent to .104 parasites/mL), but it was
specific for T. b. rhodesiense at the concentrations tested (10 pg to
0.1 fg DNA/mL equivalent to 102 to 1023 parasites/mL). Negative
controls included the eukaryotic protozoan parasites Babesia microti,
Plasmodium falciparum, Plasmodium ovale, and Toxoplasma gondii, as well
as DNA from clinical samples or spiked blood samples, such as
Borrelia burgdorferi, Borrelia crocidurae, Enterococcus spp., Ehrlichia
chaffeensis, Escherichia coli, Pseudomonas aeruginosa, Rickettsia parkeri,
Staphylococcus spp., and DNA from mouse and human blood.
Furthermore, using PSEUDO-SRA LAMP under carefully con-
trolled conditions, no false positives were found when DNA from
192 normal human CSF samples was tested. Although it is possible
to detect very low parasite numbers using Psuedo-SRA LAMP, the
assay’s sensitivity is a potential drawback because of risk for
amplicon contamination. Therefore, until more validation is done,
we do not propose PSEUDO-SRA LAMP for diagnosis of T. b.
rhodesiense. However, the range of sensitivity made it an ideal choice
to study the effects of detergent on increasing the ability of LAMP
to detect live parasites in biological samples.
LAMP in human CSF spiked with parasites
To mimic a clinical situation, we first tested RIME LAMP and
PSEUDO-SRA LAMP on human CSF spiked with live T. b.
rhodesiense IL1852 and analyzed the reaction products on agarose
gels, HNB reaction, and/or real-time LAMP based on turbidimetric
readings. As predicted, the LAMP assays had a detection limit of 103
parasites per mL based on 1 mL assay samples for RIME (Fig. 2) and
PSEUDO-SRA LAMP (Fig. 3). While sensitivity could be increased
up to 10 fold by increasing CSF sample volume to 10 mL (not
shown), the presence of detergent (i.e. 0.5% Triton X-100) alone
added to the CSF samples improved detection to 10 and 1 parasite/
mL, representing a 100 to 1000-fold increase in RIME LAMP and
PSEUDO-SRA LAMP assay analytical sensitivity, respectively
(Figs 2 and 3; Table 1). Release of parasite DNA by 0.5% Triton
required between 30 and 60 min incubation.
LAMP assay using dried blood spots (DBS) of human
blood spiked with parasites
The transport and storage of DBS or CSF on filter paper cards is a
common practice in the field. DBS on Whatman Protein Saver 903
cards are used for parasite pathogen detection (DNA, RNA and/or
protein) and genotyping [38,39,40,41,42,43]. Depending on the paper
matrix, DNA, RNA and/or protein to be tested are first extracted
from defined diameter punches (e.g. 2 mm) and 1–5 uL are assayed.
Assay sensitivity for trypanosomes is limited by the stoichiometric
presence of the parasite in the assayed sample. Analytical sensitivity is
further reduced since sample volumes in filter paper punches represent
,1% of the total captured on the paper itself [44].
We used parasite-spiked human blood spotted on dry Protein
Saver 903 cards pretreated with detergent. Remarkably, the
presence of detergent greatly enhanced LAMP detection limits for
parasite DNA by about 100 fold for RIME and PSEUDO-SRA
LAMP (Figs 4 and 5; Table 1). Enhanced detection sensitivity was
also found when T. b. rhodesiense IL1852 DNA was extracted from
DBS from Protein Saver 903 cards containing normal or
detergent-treated parasite-spiked human blood (Figs S2 and S3).
In general, replicates were more reproducible in assays where the
detergent was present in the paper. The presence of detergent had
no effect on analytical sensitivity by HNB [26], confirming its use
for easy, inexpensive, accurate, and reliable field detection of
LAMP-amplified DNA. As with any DNA amplification method,
standard precautions for avoiding template contamination [45]
also apply for LAMP-based assays.
Added Advantages
It has been shown that sensitivity, including detection of type 1
T. b. gambiense [20], can be greatly enhanced after heat denaturing
the samples before LAMP assay [16,17,20]. However, this
procedure is less convenient than simply incubating samples at
ambient temperature with detergent or allowing samples to dry on
detergent-pretreated filter cards. Aerosol effects by heating the
samples could also increase the risk of cross-contamination prior to
addition of the reaction mixture. Furthermore, the extra steps
required for techniques such as quantitative buffy coat, microhe-
Table 1. Summary of LAMP assays conducted using trypanosome spiked human CSF and blood.
LAMP assay conditions Trypanosomes/mL
Source of DNA
How sample
assayed Triton added to Primer set 104 103 102 101 100 1021 1022 None
Sample Card
CSF Direct No N/A RIME + + 2 2 2 2 nd 2
Yes N/A RIME + + + + 2 2 nd 2
No N/A PSEUDO-SRA + + – – – – nd 2
Yes N/A PSEUDO-SRA + + + + + +/– nd 2
Blood DBS No No RIME + + 2 2 2 2 nd 2
No Yes RIME + + + + 2 2 nd 2
No No PSEUDO-SRA nd + +/2 2 2 2 2 2
No Yes PSEUDO-SRA nd + + + + + + 2
Blood DBS No No RIME + + 2 2 2 2 nd 2
Yes No RIME + + + + 2 2 nd 2
No No PSEUDO-SRA + + + + 2 2 nd 2
Yes No PSEUDO-SRA + + + + + +/2 nd 2
+ = All replicates positive; +/– = positive/negative mix; 2 = All replicates negative; nd = not done; N/A = not applicable; DBS = dried blood spot on 903 card.
doi:10.1371/journal.pntd.0001249.t001
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matocrit centrifugation (mHCT), mini-anion-exchange centrifu-
gation technique (mAECT) used to concentrate the parasites from
blood or CSF [6,7] also increase contamination risk. The addition
of samples directly in the reaction helps reduce contamination.
Recent findings by Deborggraeve et al. [46] suggest that while
PCR performed better than, or similar to current parasite
detection techniques for T. b. gambiense sleeping sickness diagnosis
and staging, it cannot be used for post-treatment follow-up
because of persistence of living or dead parasites or their DNA
after successful treatment. The use of LAMP on serially diluted
sample in the absence and presence of detergent could be useful
for differentiating between these scenarios; large difference might
indicate a recent infection with small differences indicating
persistent or relapse infection. While we have not yet optimized
conditions with regards to detergent concentration or class
(nonionic, ionic or zwitterionic), our preliminary evidence supports
the concept that a detergent such as Triton X-100 can be used in a
variety of ways to enhance the analytical sensitivity of multi-copy
gene LAMP-based assays for the detection of intact African
trypanosomes in blood and CSF approximately approaching or
reaching the detection limits of LAMP for genomic DNA.
Conclusion
In addition to LAMP, the implications of these findings are far
reaching and should also be applicable for improved lateral-flow
dipstick methods recently introduced [47], PCR, or other nucleic
acid amplification-based [Recombinase Polymerase Amplification
(TwistDX), Strand Displacement Amplification (Probetec ET,
Becton-Dickinson), Nucleic Acid Sequenced Base Amplification
(Primer Biosoft International)] technologies where microbial
pathogen, including protozoan parasite (e.g. Plasmodium) DNA/
RNA could be easily released by detergents. Unlocking the
potential power of LAMP for accurate HAT diagnosis presents an
excellent option for the administration of effective anti-trypano-
some treatment. In summary, the procedure paves the way for
the adaptation of LAMP and similar technologies as simple
cost-effective diagnostics for intact African trypanosomes in
humans, animals and tsetse flies, and also for other protozoan
Figure 4. Analytical sensitivity of RIME LAMP for detection of T. b. rhodesiense DNA in human blood. T. b. rhodesiense IL1852 was spiked
into whole human blood, serially diluted and spotted in duplicate on Protein Saver 903 cards or 903 cards pretreated with 0.5% Triton X-100 and
allowed to dry overnight. DNA from the DBS was extracted as described in the methods [37] and 1 mL aliquots assayed using RIME LAMP primers.
Normal blood (blood) or nuclease free water with or without Triton X-100 were used as controls. Each panel shows hydroxynaphthol blue reaction
tubes (top), agarose gel (center) and real-time turbidity data (bottom) from the same samples. DBS DNA from uninfected blood was used as a
negative control.
doi:10.1371/journal.pntd.0001249.g004
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parasites and microorganisms that cause diseases that plague the
developing world.
Supporting Information
Figure S1 T. b. rhodesiense IL1852 contains the SRA
gene. Genomic DNA isolated from IL1852 trypanosomes was
checked by PCR using oligonucleotide primers directed against
the SRA gene diagnostic for T. b. rhodesiense, and the TgsGP gene
diagnostic for T. b. gambiense. Positive controls included in each
reaction were ELIANE, a T. b. gambiense group 1 from Coˆte
d’Ivoire [49], and Z222, a confirmed T. b. rhodesiense from Zambia.
(TIF)
Figure S2 Analytical sensitivity of RIME LAMP for dried
blood spot detection of T. b. rhodesiense DNA from
detergent treated human blood spotted on 903 cards.
Fifty mL water (DNAse/RNAse free) or 10% Triton X-100 was
added to 950 mL human blood. T. b. rhodesiense IL1852 was spiked
into human blood without and with 0.5% (w/v) Triton X-100.
The samples were serially diluted in normal or detergent treated
blood and spotted on Protein Saver 903 cards. DNA from the DBS
was extracted [37] and 1 mL aliquots assayed using RIME LAMP
primers. Each panel shows hydroxynaphthol blue reaction tubes
(top), agarose gel (center) and real-time turbidity data (bottom)
from the same samples. DBS DNA from uninfected blood was
used as a negative control.
(TIF)
Figure S3 Analytical sensitivity of PSEUDO-SRA for
dried blood spot detection of T. b. rhodesiense DNA
from detergent treated human blood spotted on 903
cards. T. b. rhodesiense IL1852 was spiked and serially diluted into
human blood without and with 0.5% Triton X-100 (+Tx) and
Figure 5. Analytical sensitivity of PSEUDO-SRA LAMP for detection of T. b. rhodesiense DNA in human blood. T. b. rhodesiense IL1852
was spiked into whole human blood, serially diluted and spotted in duplicate on Protein Saver 903 cards or 903 cards pretreated with 0.5% Triton X-
100 (+ Tx) and allowed to dry overnight. Control blood samples without trypanosomes were spotted in quadruplicate. DNA from individual DBS
(n = 2) was extracted as described in the methods and 1 mL aliquots assayed using PSEUDO-SRA LAMP primers. DBS DNA from uninfected blood was
used as a negative control (n = 4 +/2 Triton). The number of parasites/mL blood originally present in the sample used for the assays in the panels
shown are: [A], 102/mL; [B], 101/mL; [C], 100/mL; [D], 1021/mL; [E], 1022/mL; [F], blood alone.
doi:10.1371/journal.pntd.0001249.g005
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spotted on paper cards as in Fig. 4. The DNA from the DBS was
extracted and 1 mL aliquots assayed using PSEUDO-SRA LAMP
primers. The data for each individual sample is presented as real-
time turbidity values versus LAMP reaction time. DBS DNA from
uninfected blood was used as a negative control. The number of
parasites/mL blood in the panels shown are: [A], 103/mL; [B],
102/mL; [C], 101/mL; [D], 100/mL; [E], 1021/mL; [F], blood
alone.
(TIF)
Table S1 SRA gene 59-39 sequence targeted by PSEUDO-
SRA (AJ560644).
(DOC)
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